NDC 71335-1007-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-1007
- Requested NDC
- 71335-1007-01
- Package NDCs from labels
- 71335-1007-1, 71335-1007-2, 71335-1007-3, 71335-1007-4, 71335-1007-5, 71335-1007-6, 71335-1007-7, 71335-1007-8, 71335-1007-9, 71335-1007-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1007-1 | Gabapentin | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 71335-1007-2 | Gabapentin | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 7 | |
| 71335-1007-3 | Gabapentin | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 71335-1007-4 | Gabapentin | 180 in 1 BOTTLE | TABLET, FILM COATED | 180 | 7 | |
| 71335-1007-5 | Gabapentin | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 7 | |
| 71335-1007-6 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 | |
| 71335-1007-7 | Gabapentin | 84 in 1 BOTTLE | TABLET, FILM COATED | 84 | 7 | |
| 71335-1007-8 | Gabapentin | 112 in 1 BOTTLE | TABLET, FILM COATED | 112 | 7 | |
| 71335-1007-9 | Gabapentin | 135 in 1 BOTTLE | TABLET, FILM COATED | 135 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1007 | GABAPENTIN TABLET, FILM COATED [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 9 package rows | 20240410_47f2a06f-4eac-4dca-aa2a-a36dd4daaea0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-1007-1 | EA - Each | 71335-1007 | f2b25697-1f03-47d4-94fe-7a0995686db5 | 1 | 2021-07-15 |
| 71335-1007-2 | EA - Each | 71335-1007 | b791aa29-3ce5-4638-b5e7-da655acfdcb7 | 1 | 2021-07-15 |
| 71335-1007-3 | EA - Each | 71335-1007 | 52c93a4e-79e2-4248-9daf-9bd9eada6690 | 1 | 2019-09-05 |
| 71335-1007-5 | EA - Each | 71335-1007 | 9f3e7833-80d9-47e1-a2f1-b44d11da9d70 | 1 | 2019-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 75418d32-6504-4cb4-b3a9-afa0eaf19b8d | 2024-04-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 1ec656c9-034f-4f14-9e6b-9779d41e1627 | 2024-04-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8de89818-805a-4a20-a9b1-48cf443b6315 | 2024-04-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 9efd0261-9fc9-4dc9-8cf3-9110157ddfc4 | 2024-04-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | b4954172-5439-48fd-8348-8a2e0d2fee62 | 2024-04-02 | Warnings, Adverse reactions | ANDA203244 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 01b810b7-f4c8-4412-bbc5-b9220d8770d8 | 2024-04-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | c9944562-563a-423d-972c-f0313375d234 | 2024-04-02 | Warnings, Adverse reactions | ANDA203244 6CW7F3G59X |
| Clear Eyes Natural Tears | POLYVINYL ALCOHOL AND POVIDONE | Prestige Brands Holdings, Inc. | efba3eb0-798d-4635-b19b-4970e45b3cc9 | 2024-04-01 | Warnings | 532B59J990 |
| RV Illuminance Serum Tint Broad Spectrum 15 | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 132aab60-da19-7079-e063-6394a90a1d76 | 2024-03-27 | Warnings | 15FIX9V2JP |
| RV Illuminance Serum Tint Broad Spectrum 15 Amber | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 2a0ac71c-e53a-5ff9-e063-6394a90a4807 | 2024-03-27 | Warnings | 15FIX9V2JP |
| EltaMD UV Pure SPF47 | ZINC OXIDE AND TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc. | 9afe900b-4186-4189-a871-ad6f26fc26e4 | 2024-03-27 | Warnings | 15FIX9V2JP |
| SPF 50 Mineral Based Facial Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Hutton, Kathleen MD | 5cf0d2e3-d496-424c-ac75-70ff5b87e9ca | 2024-03-25 | Warnings | 15FIX9V2JP |
| Daily Prevention Advanced Smartblend Mineral Moisturizer SPF 75 | TITANIUM DIOXIDE AND ZINC OXIDE | Allure Labs | 141bb721-cd1c-5bba-e063-6394a90ab8fa | 2024-03-20 | Warnings | 15FIX9V2JP |
| Sunscreen-Lotion | ZINC OXIDE, TITANIUM DIOXIDE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 0511ff57-b7bd-4708-e063-6294a90a58a8 | 2024-03-20 | Warnings | 15FIX9V2JP |
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | A-S Medication Solutions | c77589fd-f68d-48b7-bd12-51f6b4cc9402 | 2024-03-20 | Warnings | 532B59J990 |
| Daily Prevention Pure Mineral Tinted Moisturizer SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | Allure Labs | 13bc141b-a30f-2661-e063-6294a90aca2b | 2024-03-15 | Warnings | 15FIX9V2JP |
| BB Ambre 30 BS SPF30 | ZINC OXIDE AND TITANIUM DIOXIDE | Allure Labs | 13a3ec97-0d0a-d639-e063-6294a90a0bf8 | 2024-03-14 | Warnings | 15FIX9V2JP |
| REFRESH CLASSIC | POLYVINYL ALCOHOL, POVIDONE | A-S Medication Solutions | 3bf6193c-56db-45ad-844c-58eb8c33cba9 | 2024-03-14 | Warnings | 532B59J990 |
| BB Blanc 30 BS SPF30 | ZINC OXIDE AND TITANIUM DIOXIDE | Allure Labs | 137a1528-c487-8bf3-e063-6294a90ade84 | 2024-03-12 | Warnings | 15FIX9V2JP |
| BB Sienna 30 BS SPF30 | ZINC OXIDE AND TITANIUM DIOXIDE | Allure Labs | 137bff4a-5156-b12c-e063-6394a90abe63 | 2024-03-12 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.